Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2004;57:417-421; doi:10.1136/jcp.2003.010058
Copyright © 2004 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2004;57:417-421
© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists

ORIGINAL ARTICLE

Aberrant tetranectin expression in human breast carcinomas as a predictor of survival

P Obrist1, G Spizzo2, C Ensinger1, D Fong1, T Brunhuber1, G Schäfer1, M Varga1, R Margreiter3, A Amberger3, G Gastl2 and M Christiansen4

1 Department of Pathology, University of Innsbruck, Muellerstr. 44, A-6020 Innsbruck, Austria
2 Division of Haematology and Oncology, University of Innsbruck
3 Tyrolean Cancer Research Institute, University of Innsbruck
4 Department of Clinical Biochemistry, Statens Serum Institut, DK-2300 Copenhagen, Denmark

Correspondence to:
Correspondence to:
Dr P Obrist
Department of Pathology, University of Innsbruck, Muellerstr. 44, A-6020 Innsbruck, Austria; Peter.Obrist{at}uibk.ac.at

Aims: Tetranectin (TN), a plasminogen kringle 4 binding protein, is thought to play a prominent role in the regulation of proteolytic processes via binding to plasminogen. The aim of this study was to evaluate the expression of TN in human breast cancer and adjacent normal breast tissue and to determine the impact of this expression on survival.

Methods: A retrospective analysis was performed on 189 patients with breast cancer, with a median follow up time of 10.6 years. The expression of TN was assessed in tumour tissue and adjacent normal breast tissue by immunohistochemistry, and the prognostic relevance of its expression in tumour cells was evaluated.

Results: TN was highly expressed in connective tissue fibres surrounding normal breast epithelium, but not in normal epithelial cells. High expression of TN in tumour cells was found in 131 (69%) of the tumour samples. By western blot analysis, no significant difference in the amount and molecular weight of TN was seen between tumour tissue and normal tissue. Strong TN immunoreactivity in tumour tissue was predictive of poor disease free and tumour specific overall survival. By multivariate analysis, high TN expression in cancer cells was an independent prognostic factor for disease free and tumour specific overall survival.

Conclusions: Our results demonstrate differential TN expression in normal and malignant breast tissue and a prognostic impact of TN protein expression in breast carcinoma tissue. These data suggest a possible role of TN in invasiveness and the metastatic spread of human breast cancer.

Keywords: tetranectin; expression; breast cancer; prognosis

Abbreviations: TBS, Tris buffered saline; TBS-T, Tris buffered saline plus Tween; TN, tetranectin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs